Both in Diagnostics
Insight Molecular Diagnostics vs VolitionRx Limited
Over the past year IMDX returned −56.0% and VNRX returned −97.7%; their daily moves had a correlation of -0.03.
IMDX −56.0% VNRX −97.7%Growth of $1, one year, split-adjusted
| Metric | IMDX | VNRX |
|---|---|---|
| Price | $2.74 | $0.1930 |
| Market cap | $89.7M | $5.8M |
| Today | −4.20% | −8.14% |
| 1 month | −25.3% | −16.8% |
| 6 months | −40.2% | −91.7% |
| Year to date | −63.5% | −96.2% |
| 1 year | −54.4% | −97.8% |
| Revenue growth (YoY) | −53.9% | −2.0% |
| Gross margin | 65.7% | 100.0% |
| Net margin | −4711.3% | −1953.1% |
| P/E (TTM) | — | — |
| Price / sales | 53.7× | 2.4× |
| Net cash | $17.8M | -$8.3M |
| Dividend yield | — | — |
| Volatility (60d) | 95.6% | 117.6% |
| Short % of float | 3.7% | 5.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).